|
|
|
|
Antibiotics for acute bronchitis - [Medication] - Quest Diagnostics Patient Health Library
Antibiotics for acute bronchitis References Citations Gonzales RG, et al.
Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Antibiotics for acute bronchitis - [Medication] - Quest Diagnostics Patient Health Library Antibiotics for acute bronchitis - [Medication] - Quest Diagnostics Patient Health Library...
|
|
|
Tetracycline for urinary tract infections (UTIs) - [Medication] - Quest Diagnostics Patient Health Library
Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Tetracycline for urinary tract infections (UTIs) - [Medication] - Quest Diagnostics Patient Health Library Tetracycline for urinary tract infections (UTIs) - [Medication] - Quest Diagnostics Patient Health Library Urinary system, Achromycin, Achromycin V,...
|
|
|
Antibiotics for acute bronchitis - [Medication] - Quest Diagnostics Patient Health Library
Antibiotics for acute bronchitis Examples Brand Name Chemical Name Bactrim, Septra, Sulfatrim trimethoprim and sulfamethoxazole combination Doryx, Monodox, Vibramycin doxycycline EryPed, Eryc, Ery-Tab erythromycin Zithromax azithromycin Biaxin, Biaxin XL clarithromycin Amoxicot, Amoxil, Biomox, Dispermox amoxicillin Ketek telithromycin How It Works Antibiotics slow or stop the...
|
|
|
http://www.fda.gov/cder/orange/appendix_a.txt
IN PLASTIC CONTAINER, METRONIDAZOLE METRO I.V., METRONIDAZOLE METROCREAM, METRONIDAZOLE METRODIN, UROFOLLITROPIN METROGEL, METRONIDAZOLE METROGEL-VAGINAL, METRONIDAZOLE METROLOTION, METRONIDAZOLE METROMIDOL, METRONIDAZOLE METRONIDAZOLE HCL, METRONIDAZOLE HYDROCHLORIDE METRONIDAZOLE IN PLASTIC CONTAINER, METRONIDAZOLE METRONIDAZOLE, METRONIDAZOLE METUBINE IODIDE, METOCURINE IODIDE...
|
|
|
Drug Preparedness and Response to Bioterrorism
Food and Drug Administration • Center for Drug Evaluation and Research Drug Information- Search Drug Preparedness and Response to Bioterrorism To help prepare our country for possible bioterrorism attacks, FDA is working with other federal agencies to make sure adequate supplies of medicine and vaccines are available to the American public.--This web page provides links to the...
author: USERNAME
|
|
|
First-Time Generics - December 2002
Food and Drug Administration • Center for Drug Evaluation and Research Drug Information Search First-Time Generics - December 2002 - Generic Drug Name Generic Manufacturer Brand Name Approval Date 1 AMANTADINE HYDROCHLORIDE TABLETS 100 MG UPSHER-SMITH LABORATORIES, INC
SYMMETREL TABLETS 12/16/02 2 DILTIAZEM HYDROCHLORIDE FOR INJECTION 100 MG ADD-VANTAGE VIALS ABBOTT...
author: OGD
|
|
|
Doxcycline and Penicillin G Procaine for Inhalational Anthrax (Post-Exposure)
Food and Drug Administration • Center for Drug Evaluation and Research Drug Information Search Doxycycline and Penicillin G Procaine for- Inhalational Anthrax (Post-Exposure) Doxycycline and penicillin G procaine are antibiotics used to treat bacterial infections in many different parts of the body
Use of doxycycline in children under 8 presents special concerns because of...
|
|
|
Doxycycline: Use by pregnant & lactating women
Food and Drug Administration • Center for Drug Evaluation and Research Drug Information Search Doxycycline (Vibramycin, Monodox, Doryx, Doxy, Atridox, Periodox, Vibra-Tabs) Use by Pregnant and Lactating Women Doxycycline is approved for the treatment of anthrax 1
Doxycycline should be used for prophylaxis only when there are contraindications to the...
author: USERNAME
|
|
|
FDA Drug Approvals List June 2002
- Drug Approvals for June 2002 Definitions and Notes Original New Drug Applications Original Application # 021316 Approval Date: 26-JUN-02 Trade Name: ALTOCOR Chemical Type: 3 Therapeutic Potential: S Dosage Form: TABLET Applicant: AURA LABORATORIES INC Active Ingredient(s): LOVASTATIN OTC/RX Status: RX INDICATION OF USE: For lowering total cholesterol and LDL-C to target levels as...
|
|
|
FDA Drug Approvals List March 2002
- Drug Approvals for March 2002 Definitions and Notes Original New Drug Applications Original Application #: 020855 Approval Date: 21-MAR-02 Trade Name: MESNA Chemical Type: 3 Therapeutic Potential: S Dosage Form: TABLET Applicant: ASTA MEDICA AG Active Ingredient(s): MESNA OTC/RX Status: RX Indication(s): For the use as a prophylactic agent in reducing the incidence of ifosfamide...
|
|
|
ranbaxy
- -- - - - - You are here :- Home - News Room - - Press Releases - December 2000 Ranbaxy receives FDA approvals for 4 ANDA's representating 9 formulations in the US December 04, 2000, New Delhi Ranbaxy ...
|
|
|
http://www.fda.gov/cder/foi/appletter/2000/65055ltr.pdf
ANDA 65- 055 December 1, 2000 Par Pharmaceutical, Inc
Attention: Michelle Bonomi- Huvala One Ram Ridge Road Spring Valley, NY 10977 Dear Madam: This is in reference to your abbreviated new drug application dated November 5, 1999, submitted pursuant to Section 505( j) of the Federal Food, Drug, and Cosmetic Act (Act), for Doxycycline Capsules USP, 50 mg and 100 mg
We have...
|
|
|
http://www.fda.gov/cder/foi/appletter/2000/65055ltr.pdf page 1
|
|
|
Drug Approvals - M
Product Name Company Application # Approval Date Letter Posted Label Posted Review Posted M-Zole 3 Combination Pack [Miconazole Nitrate Vaginal Suppositories USP, 200 mg and Miconazole Cream USP, 2% (Combination package)], OTC, Alpharma ANDA 74-926 4/16/99 4/28/99 - 1/14/02 Macrobid (nitrofurantoin monohydrate/macrocrystals) Capsules,- Procter & Gamble NDA 20-064/S-014 10/31/03 11/5...
|
|
|
1997 Warning Letters and Notice of Violation Letters to Pharmaceutical Companies
Food and Drug Administration • Center for Drug Evaluation and Research Compliance Activities Search Warning Letters and Untitled Letters to Pharmaceutical Companies 1997 These letters, sorted by month, are supplied by the CDER Freedom of Electronic Information Office
DDMAC 3/4/1997 Claritin-D 24 Hour (10 mg loratadine & pseudoepherine 240 mg sulfate) extended-release tablets...
|
|
|
1998 Warning Letters and Untitled Letters to Pharmaceutical Companies
Food and Drug Administration • Center for Drug Evaluation and Research Compliance Activities Search Warning Letters and Untitled Letters to Pharmaceutical Companies 1998 These letters, sorted by month, are supplied by the CDER Freedom of Electronic Information Office
Thompson Hosptial Institutional Review Board (IRB) Inspection FF Thompson Healthcare Systems DSI 4/14 6/5...
|
|
|
Reference Listed Drug Labeling Approved in June 2002
Approval Date Product Name - - Active Ingredient(s) Dosage Form NDA No Supp No -- TRIZIVIR -- letter label abacavir sulfate, lamivudine, zidovudine tablets 21-205 SLR 004 -Jun 4 CAFERGOT letter label ergotamine tartrate and caffeine suppositories 09-000 SLR 022 -- M.V.I.-12 letter - multi-vitamins for infusion injection 08-809 SLR 046 --- PEPCID injection letter label famotidine...
author: USERNAME
|
|
|
Reference Listed Drug Labeling Approved in March 2002
Approval Date Product Name Active Ingredient(s) Dosage Form NDA No Supp No Mar 1 BICILLIN C-R letter - penicillin G benzathine/ procaine injection 50-138 S-219 - BICILLIN L-A letter - penicillin G benzathine/ procaine injection 50-141 S-215 - COLY-MYCIN S letter - colistin & neomycin sulfates/thonzonium Br /hydrocortisone acetate otic suspension 50-356 S-045 - CUROSURF letter label...
author: USERNAME
|
|
|
D:\N50641 Monodox\S008 AP.doc page 1
author: Judit Milstein
|
|
|
D:\N50641 Monodox\5010 AP.DOC page 1
author: Judit Milstein
|
